+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effects of darbepoetin alpha on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy



Effects of darbepoetin alpha on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy



American Heart Journal 155(4): 751.E1-7



Background Anemia is a frequent condition in chronic heart failure (CHF) that affects adversely long-term cardiac outcomes. We sought to investigate the effects of recombinant human erythropoietin analogue darbepoetin alpha on left (LV) and right ventricular (RV) function and neurohormonal activation in patients with CHF and anemia.Methods Thirty-two CHF patients (New York Heart Association class II-III, LV ejection fraction [EF] <40%, hemoglobin level < 12.5 9/dL, serum creatinine level <2.5 mg/dL) were randomized (2: 1) to receive either a 3-month darbepoetin alpha regimen at 1.5 mu g/kg every 20 days plus oral iron (n = 2 1) or placebo plus oral iron (n = 11). Echocardiographic indices of LV systolic and diastolic function and RV function, plasma B-type natriuretic peptide (BNP) and 6-minute walked distance were assessed at baseline and posttreatment.Results Regarding LV function, only treatment with darbepoetin a caused a significant improvement in LVEF (F = 22.001, P<.001), end-systolic wall stress (F = 4.934, P =.03A), mitral annulus systolic displacement (F = 6.710, P<.015), isovolumic relaxation time (F = 4.909, P =.035), and E/e ratio (F = 7.833, P =.009). The RV systolic pressure (F = 7.715, P =.009) as well as tricuspid annulus systolic displacement and RVEF (F = 9.264, P =.005) were significantly improved only in the darbepoetin a group. Darbepoetin a had also a beneficial effect on New York Heart Association class (F = 14,586, P =.001), plasma BNP (F = 14.781, P =.001), and 6-minute walk test (F = 19.926, P <.001), whereas these parameters did not significantly change in the placebo-treated patients.Conclusion Darbepoetin a improves both LV and RV performance and exercise capacity and counteracts neurohormonal activation in CHF patients with anemia. The drug effects on LV diastolic function, RV function, and LV end-systolic wall stress, in particular, are novel findings, with a potential important contribution to patients' symptomatic improvement.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 031148133

Download citation: RISBibTeXText

PMID: 18371487

DOI: 10.1016/j.ahj.2008.01.016


Related references

Effects of darbepoetin alpha on right and left ventricular systolic secondary to ischemic or idiopathic dilated cardiomyopathy. American Heart Journal 155(4): Article No.: e7, 2008

Effects of Darbepoetin Alfa on plasma mediators of oxidative and nitrosative stress in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. American Journal of Cardiology 103(8): 1134-1138, 2009

Prognostic value of tissue Doppler right ventricular systolic and diastolic function indexes combined with plasma B-type natriuretic Peptide in patients with advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. American Journal of Cardiology 105(2): 249-254, 2010

Comparison of left ventricular systolic and diastolic function in patients with idiopathic dilated cardiomyopathy and mild heart failure versus those with severe heart failure. American Journal of Cardiology 90(4): 390-394, 2002

Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy. American Journal of Cardiology 78(7): 779-784, 1996

Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. American Journal of Cardiology 93(7): 854-859, 2004

Cardiac ventricular diastolic and systolic duration in children with heart failure secondary to idiopathic dilated cardiomyopathy. American Journal of Cardiology 97(1): 101-105, 2006

Relation of exercise capacity to left ventricular systolic function and diastolic filling in idiopathic or ischemic dilated cardiomyopathy. American Journal of Cardiology 83(5): 728-734, 1999

Differential effects of milrinone and dobutamine on right ventricular preload afterload and systolic performance in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. American Journal of Cardiology 60(16): 1329-1333, 1987

Carvedilol improves symptoms and left ventricular function in patients with congestive heart failure due to ischemic or idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology 21(2 Suppl. A): 114A, 1993

Noninvasive evaluation of systolic and diastolic function in severe congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. American Journal of Cardiology 57(15): 1315-1322, 1986

Relations among heart failure severity, left ventricular loading conditions, and repolarization length in advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. American Journal of Cardiology 92(5): 544-547, 2003

Effects of afterload reduction diuretics and vasodilators on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. American Journal of Cardiology 60(8): 654-658, 1987

The acute hemodynamic effects of right ventricular septal pacing in patients with congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. American Journal of Cardiology 79(5): 679-681, 1997

Effects of cardiac sympathetic blockade on left ventricular diastolic function in patients with dilated cardiomyopathy and severe heart failure. Zhonghua Yi Xue Za Zhi 86(17): 1170-1173, 2006